Goodluck Defence and Aerospace : The 155mm Shell Factory That India Needed and Has Now Built

• Goodluck Defence and Aerospace Limited just received a domestic order to supply 20,000 of them for ₹52.20 crore, to be delivered within three months

• The facility that will produce those shells was built in Sikandarabad, Bulandshahr, Uttar Pradesh at an investment of ₹216.50 crore. It reached operational readiness in FY25, completed regulatory approvals through Q1 FY26, and began commercial production thereafter. In October 2025, the parent company disclosed to BSE and NSE that the subsidiary would expand capacity from 1,50,000 to 4,00,000 shells per year within 12 months, deploying an additional ₹500 crore. The first publicly disclosed commercial order arrived May 27, 2026.

• India's artillery modernisation programme is the largest in the country's defence history. The Bofors FH77B howitzer fleet (inducted 1986, over 400 guns), the K9 Vajra self-propelled system (100 guns inducted, more ordered), the M777 ultra-light howitzer (145 guns), and the upcoming Advanced Towed Artillery Gun System (ATAGS) all fire one calibre: 155mm. The Indian Army estimates it needs approximately 5 lakh rounds per year to maintain operational readiness. Before 2024, domestic private sector production of 155mm shells was essentially zero. Government ordnance factories produced some quantities but far below the operational requirement. The gap was filled by imports, with attendant strategic vulnerability.

• The indigenisation of 155mm shell production is therefore not an opportunity in the conventional commercial sense. It is a national security imperative with a captive, sovereign customer, a quantity requirement that far exceeds current domestic supply, and government policy that explicitly mandates switching from import to domestic sourcing under the Positive Indigenisation List and Aatmanirbhar Bharat frameworks.

• Goodluck Defence and Aerospace Limited is the private sector's most significant answer to that imperative.

Who Built This and How?

• Goodluck Defence and Aerospace Limited was incorporated on August 31, 2023 (CIN: U24103UP2023PLC188289) as a wholly-owned subsidiary of Goodluck India Limited (CIN: L74899DL1986PLC050910; NSE: GOODLUCK; BSE: 530655). Goodluck India is a 40-year-old precision steel manufacturer with ₹3,935 crore in FY25 revenue, 1.94 lakh MT annual production capacity, and a client base of 600-plus organisations across 100 countries. The decision to enter defence manufacturing was not a diversification away from core competence. It was an extension of it.

• On December 19, 2023, Goodluck India disclosed to BSE and NSE that it was establishing, through the subsidiary, a new facility at Sikandarabad, Dist. Bulandshahr, Uttar Pradesh, for forging, machining, treatment, and coating of steel, stainless steel, special steel, and alloys for the defence and aerospace industry. The investment was announced at approximately ₹216.50 crore, funded through equity and debt, targeting 11,000 MT per annum processing capacity.

• On January 4, 2025, a subsequent Regulation 30 update confirmed: machinery erection had started. Trial production was expected to begin by Q1 FY26 (April-June 2025).

• The Sikandarabad location is significant. Goodluck India's existing works at A-42 and A-45, Industrial Area, Sikandarabad, Dist. Bulandshahr, have operated for decades. The defence subsidiary was deliberately co-located to leverage proven industrial infrastructure, utilities, logistics connectivity, and operational security. This is not a greenfield facility in a vacuum; it is a purpose-built extension of a functioning precision manufacturing ecosystem.

FY25: The Capital Deployment Year

The Financial Statements for FY25 (year ended March 31, 2025), audited by M/s Sanjeev Anand & Associates (Firm Registration No. 007171C), confirm the following with an unmodified audit opinion:

• Total income: ₹6.99 crore. This figure is entirely interest income earned on capital deployed during the facility construction and commissioning period, before operational production commenced. Revenue from operations: nil. Depreciation: nil (assets not yet placed in service, consistent with awaiting regulatory approvals to commence production). Finance costs: ₹1.72 crore (interest on debt facilities partially drawn). Profit before tax: ₹5.25 crore. Profit after tax: ₹3.88 crore. Basic EPS: ₹0.79.

• The Directors' Report of the 2nd Annual Report is unambiguous: "during the period under review, though the Company has not started its business operations however, it has earned Rs.698.50 lakhs as interest income. Further, the Company has completed installation of its manufacturing facility and is waiting for regulatory approval to commence the production."

• As at March 31, 2025, the plant was physically complete, equipped, and installed. The only outstanding step was regulatory approval for commencement of production of defence-specific components. Capital expenditure in FY25 alone was ₹208.16 crore, taking total capex through FY25 to approximately ₹228 crore.

• The balance sheet as at March 31, 2025 reflects the character of a capital deployment company: equity of approximately ₹172 crore (comprising ₹49.11 crore paid-up capital and approximately ₹123 crore in securities premium, largely from parent company funding at premium to face value), debt of approximately ₹58 to 65 crore (including an HDFC Bank facility of ₹55 crore registered August 2024), and capital work-in-progress representing the facility under installation.

October 2025: The Expansion That Confirmed Phase 1 Was Running

• On October 10, 2025, Goodluck India filed a material subsidiary disclosure under Regulation 30 of the SEBI (LODR) Regulations with both BSE and NSE. The disclosure announced that Goodluck Defence and Aerospace Limited had decided to expand production capacity for empty shells from 1,50,000 to 4,00,000 shells per year within one year, with an investment of approximately ₹500 crore.

This filing is the most important single document in understanding the investment thesis.

• First, it confirms that by October 2025, Phase 1 capacity of 1,50,000 shells per year was operational. You cannot expand from a baseline that doesn't exist. The regulatory approvals referenced in the FY25 Annual Report were obtained, trial production (expected Q1 FY26) was completed, and commercial production was running by the time the expansion decision was made.

• Second, the ₹500 crore expansion scale speaks directly to the demand visibility the management had in hand. Capital allocators do not commit ₹500 crore to add 2,50,000 shells per year in capacity without binding demand signals. The expansion brings total invested capital in Goodluck Defence to approximately ₹716.50 crore (₹216.50 crore Phase 1 plus ₹500 crore Phase 2), targeting 4 lakh shells per year, to be completed within one year.

• Third, Goodluck India's characterisation of this as a Material Subsidiary disclosure under SEBI regulations confirms the scale of the subsidiary's strategic and financial significance relative to the parent. This is no longer a proof-of-concept venture.

May 2026: The First Order

On May 27, 2026, Goodluck India filed an order disclosure under Regulation 30 of SEBI (LODR) Regulations 2015. The Company received an order for the supply of 20,000 nos. 155mm shell in Ready to Fill Conditions.

• The Regulation 30 annexure (Annexure-A) confirms: customer not disclosed (confidentiality), domestic entity, not a related party, delivery schedule within three months, order value approximately ₹52.20 crore. Revenue per shell: ₹26,100.

• At Phase 1 capacity of 1,50,000 shells per year: annualised revenue at this realisation = ₹391.5 crore. At Phase 2 capacity of 4,00,000 shells per year: annualised revenue = ₹1,044 crore.

• Neither of these numbers appears in any Goodluck Defence annual report yet. Both are directly calculable from the two regulatory filings.

• The "Ready to Fill Conditions" formulation is standard in Indian defence ammunition procurement. The shell body (casing) is manufactured to specification, tested, and delivered to an authorised filling station (typically an Ordnance Factory or designated government facility) where the explosive propellant charge and fuze are added. This division of labour allows private sector manufacturers to participate in shell production under appropriate licensing, while explosive handling remains within secure government facilities. Goodluck Defence's manufacturing scope is the precision engineering of the shell body, which is the higher-specification, higher-value component of the ammunition round.

Valuation : The Investment Is in What Hasn't Been Reported Yet

• At ₹370 : Market capitalisation is ₹1,817 crore.

• FY25 PAT of ₹3.88 crore gives a P/E of 468 times. This number is analytically meaningless for a pre-revenue capital deployment company and should not be used. The P/B of 10.54 times on FY25 book value of ₹35.10 per share is more contextually relevant but still reflects a pre-operational balance sheet.

• The correct valuation frame is : what did you pay for the capacity, and what is that capacity worth in earnings terms?

• Capital committed (Phase 1 + Phase 2): ₹716.50 crore. Price-to-invested-capital at ₹370 OTC: ₹1,817 / ₹716.50 = 2.54 times.

• For comparison, listed defence manufacturers in India with confirmed order books and operational revenue trade at 5 to 12 times invested capital and 40 to 80 times earnings. At Phase 2 operational revenue of ₹1,044 crore with a 10 to 12% net margin (a conservative range for a defence contract manufacturer with high barriers to entry and captive demand), PAT would approximate ₹100 to ₹125 crore. At 35 to 40 times P/E (the range at which comparable listed Indian defence companies trade): implied market cap = ₹3,500 to ₹5,000 crore. Per share: ₹713 to ₹1,018.

• These are not projections. They are valuation benchmarks at different assumed margin and multiple combinations. The risk is that Phase 2 takes longer than planned, margins are lower than assumed, or additional equity dilution from the ₹500 crore expansion compresses the per-share numbers. All of these are real risks and addressed below. The opportunity is that at ₹370, the market is pricing in none of these scenarios.

Management

• Shri Mahesh Chandra Garg (DIN: 00292437) serves as Whole Time Director of Goodluck Defence and is also a Director of Goodluck India Limited, providing direct governance continuity between the parent and subsidiary. Shri Ramesh Chandra Garg (DIN: 00298129) also serves as Whole Time Director and is a Director of Goodluck India. Shri Shambhu Nath Singh (DIN: 09847470) was appointed Whole Time Director with effect from October 1, 2025, transitioning from his role as Whole Time Director of Goodluck India, where he has over 30 years of industry experience.

• Independent directors: Shri Madhur Gupta (Non-Executive Independent) and Ms. Charu Jindal (Non-Executive Woman Independent).

• CFO: Mr. Arun Kumar. Company Secretary: Mr. Jagdish Pratap (M.No. A67532, appointed March 1, 2025). RTA: M/s Nivis Corpserve LLP, Delhi.

• Statutory Auditors: M/s Sanjeev Anand & Associates, Chartered Accountants (Firm Registration No. 007171C), appointed for five years from the 1st AGM.

The Garg family's direct governance presence in both the parent and subsidiary ensures strategic alignment and management bandwidth on the defence manufacturing ramp-up. Shambhu Nath Singh's appointment to the subsidiary board in October 2025, coinciding with the expansion announcement, signals that senior management resources are being transferred to accelerate the scale-up.

KEY RISKS :

No Operational Revenue Track Record FY25 income is entirely interest on invested capital. The company has no audited revenue from defence manufacturing, no cost-per-shell data, and no margin history. The ₹52.20 crore first order is the earliest revenue data point. Profitability at scale is an assumption, not an established fact.

₹500 Crore Expansion Requires Significant External Funding The Phase 2 expansion of ₹500 crore, to be completed within 12 months from October 2025, will require substantial new equity or debt. If funded through equity, the per-share dilution could materially reduce the value of existing holders. If funded through debt, the balance sheet leverage increases significantly and introduces refinancing risk if order inflows are slower than planned. The funding mechanism has not been publicly specified.

Government Customer Concentration The 155mm shell order is from a domestic defence entity, almost certainly a government or quasi-government buyer. Defence procurement in India is chronically delayed, frequently interrupted by tender revisions, and dependent on allocation from the Ministry of Defence capital budget. Revenue recognition is tied entirely to customer acceptance and delivery sign-off, both of which are subject to inspection requirements that can extend delivery timelines.

Certification and Regulatory Risk Artillery shells require DGQA (Directorate General of Quality Assurance) certification and specific production licences under the Explosives Rules and Arms Act framework. Any quality deviation, inspection failure, or regulatory non-compliance would halt deliveries and potentially trigger order cancellation. The company does not yet have a certified production history across multiple orders.

Competition from Government and Established Private Sector Ordnance Factory Board (now Munitions India Limited and others under corporatisation), Bharat Forge (Kalyani Group), Economic Explosives Limited, and potentially other entrants are competing for the same indigenisation mandate. Government entities have legacy relationships and procurement advantages. Bharat Forge has significant forging and machining capability. Goodluck Defence's competitive moat is meaningful but not absolute.

Parent Company Dependency Without Formal Guarantee While Goodluck India's backing provides implicit financial support, manufacturing credibility, and governance capacity, there is no disclosed formal guarantee of financial support to the subsidiary. If Goodluck India faces a challenging financial period, the subsidiary's access to capital could be constrained.

Illiquidity and No IPO Timeline Disclosed There is no announced IPO date or listing plan. OTC investors have no guaranteed exit mechanism and no exchange-based price discovery. The current OTC price of ₹370 is arrived at by market participants without a regulated secondary market. Exit depends on finding a willing buyer.

KEY OPPORTUNITIES :

• India's 155mm Ammunition Gap Is Structural, Not Cyclical : The Indian Army's requirement for 155mm shells is estimated at approximately 5 lakh rounds per year. Domestic private sector production was close to zero before 2024. Goodluck Defence at Phase 1 capacity (1,50,000 shells/year) addresses 30% of the estimated annual requirement. At Phase 2 (4,00,000 shells/year), it addresses 80%. Even at Phase 2, demand exceeds domestic supply, providing strong revenue visibility for years.

• Positive Indigenisation List Creates Mandatory Demand : Artillery ammunition and components appear on India's Positive Indigenisation List (PIL), which progressively restricts import of these items, mandating government buyers to source domestically. This creates a compulsory domestic procurement environment, converting the Army's requirement into a guaranteed commercial opportunity for licensed domestic manufacturers. Goodluck Defence is among the first private sector entities to have production capability in this category.

• Phase 2 Revenue Potential Is Nine Times Phase 1 Deployed Capital : At 4,00,000 shells/year × ₹26,100 per shell = ₹1,044 crore annualised revenue potential. The total capital to be deployed for Phase 2 is ₹500 crore. Even at 10% PAT margin on ₹1,044 crore revenue, PAT would be ₹104 crore. At 35 times P/E (conservative for a listed Indian defence company), implied market cap = ₹3,640 crore, representing a 100% premium to current OTC market cap of ₹1,817 crore.

• First Order Validates Product, Customer Approval, and Pricing : The May 2026 order at ₹52.20 crore for 20,000 shells is the critical proof-of-concept milestone. It confirms: the shell has cleared DGQA quality inspection, the production licence is in place, the facility is operationally certified, the pricing is acceptable to a sovereign buyer, and the delivery commitment is achievable within three months. Every subsequent order will benefit from this established approval foundation.

• Capacity Utilisation Is the Only Financial Driver From Here : The infrastructure investment is substantially complete (Phase 1) or committed (Phase 2). Fixed costs are largely locked in. Revenue growth from here is volume-driven, and at current capacity levels, incremental revenue should produce disproportionate earnings growth as fixed overheads are absorbed. The operating leverage will be visible in the first full-year of production financials.

• Export Market Optionality : India is emerging as an artillery ammunition exporter under the government's defence export push (target: ₹50,000 crore in exports by 2029). 155mm shells produced to NATO standards are exportable to markets across Africa, Southeast Asia, and NATO-allied nations seeking alternative suppliers. Export revenue carries higher realisations than domestic government procurement and diversifies the customer base beyond the single sovereign buyer.

• Parent Company Provides 40 Years of Manufacturing Credibility : Goodluck India's existing relationships with 600-plus global clients, quality certifications, supply chain infrastructure, and management depth are directly transferable to the subsidiary's defence operations. The co-location at Sikandarabad leverages shared utilities, logistics, and security infrastructure. The parent's track record reduces the technology and execution risk inherent in any new defence manufacturing venture.

Disclaimer: The financial data presented on this page for FY25 is sourced from the 2nd Annual Report of Goodluck Defence and Aerospace Limited for the financial year ended March 31, 2025, audited by M/s Sanjeev Anand & Associates (Firm Regn. No. 007171C) with an unmodified audit opinion. Corporate disclosures relating to the facility investment, expansion plan, and first order are sourced from Regulation 30 filings submitted by Goodluck India Limited (BSE Scrip Code: 530655; NSE Symbol: GOODLUCK) to BSE and NSE on January 4, 2025, October 10, 2025, and May 27, 2026 respectively. Revenue and earnings projections referenced herein are illustrative scenario analyses based on disclosed capacity and per-unit realisation from the May 2026 order; they are not forecasts, guidance, or guaranteed outcomes. This content is intended solely for informational and educational purposes and does not constitute investment advice, a solicitation to buy or sell securities, or a recommendation of any kind. Goodluck Defence and Aerospace Limited is a pre-revenue company in FY25 with no operational earnings history. The investment involves significant risks including but not limited to: absence of operational revenue track record, dependence on government defence procurement timelines, uncertainty of future orders, equity dilution risk from the ₹500 crore Phase 2 expansion, regulatory and certification risk, competition from other domestic and government-owned manufacturers, and illiquidity of OTC unlisted shares. Prospective investors are strongly advised to conduct independent due diligence and consult a SEBI-registered investment advisor before making any investment decision. Priveq.in does not guarantee the accuracy, completeness, or timeliness of information provided and accepts no liability for investment decisions made in reliance on this content.